By protein interaction screening using a radioactive LMO2 protein probe we have isolated a LIM domain binding protein. The gene shows high homology to independently isolated genes from mouse, Xenopus and Drosophila called Ldb1/Nli/Clim-2, Xldb1 and Chip, respectively. The human and mouse genes differ by only two amino acids, suggesting that the gene that we have isolated is the human homologue. Here we describe the genomic organization, alternative transcript forms and the chromosome mapping of the human gene LDB1 (alias NLI). The gene is spread over at least 12 kb and has 11 exons. Preceding the described ATG initiation site in the mouse a highly conserved region between mouse, chicken and human was detected with a second possible in frame initiation site coding for further 36 amino acids. An alternative splice site adding six nucleotides corresponding to the addition of two amino acids at the end of exon 10 was found. The gene was mapped to chromosome 10q24→q25 by in situ hybridization, a region frequently deleted in many types of cancer. Fine mapping with a radiation hybrid panel localized the gene in the interval between the markers D10S603 and D10S540.   

1.
Agulnick AD, Taira M, Breen JJ, Tanaka T, Dawid IB, Westphal H: Interactions of the LIM-domain-binding factor Ldb1 with LIM homeodomain proteins. Nature 384:270–272 (1996).
2.
Bach I, Rhodes SJ, Pearse RV II, Heinzel T, Gloss B, Scully PE, Sawchenko PE, Rosenfeld MG: P-Lim, a LIM homeodomain factor, is expressed during pituitary organ and cell commitment and synergizes with Pit-1. Proc Natl Acad Sci, USA 92:2720–2724 (1995).
3.
Bach I, Carrière C, Ostendorff, HP, Andersen B, Rosenfeld MG: A family of LIM domain-associated cofactors confer transcriptional synergism between LIM and Otx homeodomain proteins. Genes Dev 11:1370–1380 (1997).
4.
Boehm T, Foroni L, Kaneko Y, Perutz MP, Rabbitts, TH: The rhombotin family of cysteine-rich LIM-domain oncogenes: Distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proc Natl Acad Sci, USA 88:4367–4371(1991).
5.
Breen JJ, Agulnick AD, Westphal H, Dawid, IB: Interactions between LIM domains and the LIM domain-binding protein Ldb1. J biol Chem 273:4712–4717 (1998).
6.
Dawid IB, Toyama R, Taira M: LIM domain proteins. C r Acad Sci Ser. III 318:295–306 (1995).
7.
Fernández-Fúnez P, Cheng-Hsin L, Rincón-Limas DE, García-Bellido, Botas J: The relative expression amounts of apterous and its co-factor dLdb/Chip are critical for dorso-ventral compartmentalization in the Drosophila wing. EMBO J 17:6846–6853 (1998).
8.
Feuerstein R, Wang X, Song D, Cooke NE, Liebhaber SA: The LIM /double zinc finger motif functions as a protein dimerization domain. Proc natl Acad Sci, USA 91:10655–10659 (1994).
9.
German MS, Wang J, Chadwick RB, Rutter WJ: Synergistic activation of the insulin gene by a LIM-homeodomain protein and a basic helix-loop-helix protein: Building a functional insulin minienhancer complex. Genes Dev 6:2165–2176 (1992).
10.
Jurata LW, Kenny DA, Gill GN: Nuclear LIM interactor, a rhombotin and LIM homeodomain interacting protein, is expressed early in neuronal development. Proc natl Acad Sci, USA 93:11693–11698 (1996).
11.
Jurata LW, Gill GN: Functional analysis of the nuclear domain interactor NLI. Mol Cell Biol 17:5688–5698 (1997).
12.
Jurata LW, Pfaff SL, Gill GN: The nuclear LIM domain interactor NLI mediates homo- and heterodimerization of LIM domain transcription factors. J biol Chem 273:3152–3157 (1998).
13.
Kaelin WG, Krek W, Sellers WR, DeCaprio JA, Ajchenbaum F, Fuchs CS, Chittenden T, Li Y, Farnham PJ, Blanar MA, Livingston DM, Flemington EK: Expression cloning of a retinoblastoma-binding protein with E2F-like properties. Cell 70:351–364 (1992).
14.
Koskinen T, Santavuori P, Sainio K, Lappi M, Kallio A-K, Pihko H: Infantile onset spinocerebellar ataxia with sensory neuropathy-a new inherited disease. J Neurol Sci 121:50–56 (1994).
15.
Larson R, Fisch P, Larson T, Lavenir I, Langford T, King G, Rabbitts TH: T cell tumors with disparate phenotypes develop with long latency in mice transgenic for rbtn2. Oncogene 9:3675–3681 (1994).
16.
Lichter P, Tang CJ, Call K, Hermanson G, Evans GA, Housman D, Ward DC: High resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science 247:64–69 (1990).
17.
Milán M, Diaz-Benjumea FJ, Cohen SM: Beadex encodes an LMO protein that regulates Apterous LIM-homeodomain activity in Drosophila wing development: a model for LMO oncogene function. Genes Dev 12:2912–2920 (1998).
18.
McGuire EA, Hockett RD, Pollock KM, Bartholdi MF, O’Brien SJ, Korsmeyer SJ: The t(11;14)(p15;q1) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein. Mol Cell Biol 9:2124–2132 (1989).
19.
Morcillo P, Rosen C, Dorsett D: Genes regulating the remote wing margin enhancer in the Drosophila cut locus. Genetics 144:1143–1154 (1996).
20.
Morcillo P, Rosen C, Baylies MK, Dorsett D: Chip, a widely expressed chromosomal protein required for segmentation and activity of a remote wing margin enhancer in Drosophila. Genes Dev 11:2729–2740 (1997).
21.
Rabbitts TH: LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes. Genes Dev 12:2651–2657 (1998).
22.
Royer-Pokora B, Loos U, Ludwig, W-D: TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11). Oncogene 6:1887–1893 (1991).
23.
Sanchez-Garcia I, Rabbitts TH: Transcriptional activation by TAL1 and FUS-CHOP proteins expressed in acute malignancies as a result of chromosomal abnormalities. Proc natl Acad Sci, USA 91:7869–7873 (1994).
24.
Schmeichel KL, Beckerle MC: The LIM domain is a modular protein binding interface. Cell 79:211–219 (1994).
25.
Semina EV, Altherr MR, Murray JC: Cloning and chromosomal localization of two novel human genes encoding LIM-domain factors CLIM1 and CLIM2/LDB1/NLI. Mammal Genome 9:921–924 (1998).
26.
Shoresh M, Orgad S, Shmueli O, Werczberger R, Gelbaum D, Abiri S, Segal D: Overexpression Beadex mutations and loss-of-function heldup-a mutations in Drosophila affect the 3′ regulatory and coding components, respectively, of the Dlmo gene. Genetics 150:283–299 (1998).
27.
Ueki N, Yano K, Masuho Y, Muramatsu M: Isolation and chromosomal assignment of human genes encoding cofactor of LIM homeodomain proteins, CLIM1 and CLIM2. J hum Genet 44:112–115 (1999).
28.
Visvader JE, Mao Y, Fujiwara Y, Hahm K, Orkin SH: The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation. Proc natl Acad Sci, USA 94:13707–13712 (1997).
29.
Warren AJ, Colledge WH, Carlton MB, Evans MJ, Smith AJ, Rabbitts TH: The oncogenic cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development. Cell 78:45–58 (1994).
30.
Yamashita T, Agulnick AD, Copeland NG, Gilbert DJ, Jenkins NA, Westphal H: Genomic structure and chromosomal localization of the mouse LIM domain-binding protein 1 Gene, Ldb1. Genomics 48:87–92 (1998).
© 1999 S. Karger AG, Basel
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.